Biotechnology Stocks
| # | 이전 7일 | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 1951 |  AUPH Aurinia Pharmaceuticals Inc - Common Shares | 15.92 USD | -1.85% | -2.39% | +0.25% | +33.45% | 2.05 B USD | ||
| 1958 |  SRPT Sarepta Therapeutics, Inc. - Common Stock | 19.85 USD | +0.30% | +11.14% | +24.92% | +4.75% | 2.10 B USD | ||
| 1960 |  SION Sionna Therapeutics, Inc. - Common Stock | 43.69 USD | -2.76% | +4.20% | +34.10% | +11.06% | 1.97 B USD | ||
| 1972 |  VRDN Viridian Therapeutics, Inc. - Common Stock | 19.50 USD | -4.74% | +2.63% | +22.18% | -13.14% | 2.01 B USD | ||
| 1977 |  GLUE Monte Rosa Therapeutics, Inc. - Common Stock | 23.32 USD | -4.43% | -4.66% | +33.33% | +106.37% | 1.97 B USD | ||
| 1997 |  ATAI AtaiBeckley Inc. - Common Stock | 5.09 USD | -1.93% | -2.30% | +32.90% | +28.86% | 1.87 B USD | ||
| 1999 |  STOK Stoke Therapeutics, Inc. - Common Stock | 31.71 USD | -3.97% | -2.37% | +7.67% | +160.34% | 1.97 B USD | ||
| 2000 |  BCAX Bicara Therapeutics Inc. - Common Stock | 28.30 USD | -6.91% | -2.51% | +38.73% | +95.98% | 1.86 B USD | ||
| 2002 |  ZYME Zymeworks Inc. - Common Stock | 26.03 USD | -2.58% | +2.40% | +6.64% | +46.73% | 1.90 B USD | ||
| 2008 |  PGEN Precigen, Inc. - Common Stock | 5.48 USD | -0.54% | -1.44% | +49.73% | +214.94% | 1.95 B USD | ||
| 2009 |  ANAB AnaptysBio, Inc. - Common Stock | 64.91 USD | -3.59% | -2.45% | +24.54% | +84.40% | 1.89 B USD | ||
| 2018 |  AMLX Amylyx Pharmaceuticals, Inc. - Common Stock | 17.43 USD | -4.07% | -3.06% | +31.55% | +149.71% | 1.94 B USD | ||
| 2021 |  RXRX Recursion Pharmaceuticals, Inc. - Class A Common Stock | 3.65 USD | -4.95% | -0.82% | +9.61% | -33.03% | 1.93 B USD | ||
| 2022 |  TYRA Tyra Biosciences, Inc. - Common Stock | 31.59 USD | -1.10% | +4.60% | +15.97% | +120.29% | 1.88 B USD | ||
| 2029 |  NUVB Nuvation Bio Inc. Class A Common Stock | 5.51 USD | -2.82% | +1.29% | +8.46% | +157.48% | 1.92 B USD | ||
| 2039 |  IOVA Iovance Biotherapeutics, Inc. - Common Stock | 4.22 USD | -2.99% | +5.24% | +3.18% | +133.15% | 1.88 B USD | ||
| 2041 |  TSHA Taysha Gene Therapies, Inc. - Common Stock | 6.29 USD | -3.23% | -5.84% | +14.16% | +155.69% | 1.81 B USD | ||
| 2054 |  NBTX Nanobiotix S.A. - ADSs | 38.35 USD | -1.16% | -1.29% | +8.12% | +619.51% | 1.86 B USD | ||
| 2061 |  URGN UroGen Pharma Ltd. - Ordinary Shares | 37.03 USD | -1.91% | -2.76% | +32.34% | +94.89% | 1.80 B USD | ||
| 2074 |  ZBIO Zenas BioPharma, Inc. - Common Stock | 26.62 USD | -3.83% | -3.97% | +49.63% | +0.60% | 1.68 B USD |
뉴스 Biotechnology Stocks
스트림 파이낸스, 채권자 등록 시작해 '글로벌 합의' 절차 진행
NVIDIA, 로봇 '물리 AI'를 위한 최초의 안전 풀스택 시스템 'Halos for Robotics' 발표
아부다비 투자 플랫폼 MGX, AI 인프라 강화 위해 약 500억 달러 조달
AI 코인 다시 뛰나…DEXE·EIGEN·ALLO 등 알트코인 선별 강세
지난주 화제의 주식: 스페이스X, 인텔, 넷플릭스 등 5종목
화요일 주목받은 주식: 넷플릭스, 소파이, 스냅, 모더나 및 아워본드
짐 크레이머 "이건 중대한 사건"···코어위브·아스테라·네비우스 등 나스닥100 지수 입성
Gainers Biotechnology Stocks
 TVRD Tvardi Therapeutics, Inc. - Common Stock | 4.36 | +40.65% |
 ASBPW Aspire Biopharma Holdings, Inc. - Warrant | 0.0249 | +24.50% |
 ELTX Elicio Therapeutics, Inc. - Common Stock | 3.38 | +20.71% |
 APLMW Apollomics Inc. - Warrant | 0.0143 | +19.17% |
 CBUS Cibus, Inc. - Class A Common Stock | 1.76 | +17.33% |
 TTRX Turn Therapeutics Inc. - Common Stock | 11.37 | +17.10% |
 PRME Prime Medicine, Inc. - Common Stock | 4.57 | +14.54% |
 SILO Silo Pharma Inc -, effectuated 1:50 R/S on 9/15 | 6.41 | +13.25% |
Losers Biotechnology Stocks
 CMMB Chemomab Therapeutics Ltd - American Depositary Shares | 2.05 | -25.99% |
 BTAI BioXcel Therapeutics, Inc. - Common Stock | 0.84 | -19.23% |
 SABSW SAB Biotherapeutics, Inc. - Warrant | 0.0140 | -16.67% |
 JUNS Jupiter Neurosciences, Inc. - Common Stock | 0.19 | -13.64% |
 LTRN Lantern Pharma Inc. - Common Stock | 3.11 | -12.89% |
 MCRB Seres Therapeutics, Inc. - Common Stock | 7.16 | -12.04% |
 TVGNW Tevogen Bio Holdings Inc. - Warrant | 0.0501 | -11.64% |
 ONCO Onconetix, Inc. - Common Stock | 0.95 | -11.21% |